Terry J Fry

Summary

Affiliation: Children's National Medical Center
Country: USA

Publications

  1. ncbi Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?
    Terry J Fry
    Division, Blood Marrow Transplantation and Immunology, Center for Cancer and Blood Disorders, Children s National Medical Center, Washington, DC 10010, USA
    Pediatr Clin North Am 55:147-67, xi. 2008
  2. ncbi The graft-versus-tumor effect in pediatric malignancy
    Terry J Fry
    Division of Blood and Marrow Transplantation Immunology, Center for Cancer and Blood Disorders, Children s National Medical Center, 1 West Wing, 111 Michigan Avenue, NW, Washington, DC 20010, USA
    Pediatr Clin North Am 57:67-81. 2010
  3. ncbi Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?
    Terry J Fry
    Division, Blood Marrow Transplantation and Immunology, Center for Cancer and Blood Disorders, Children s National Medical Center, 111 Michigan Avenue NW, Washington, DC 10010, USA
    Hematol Oncol Clin North Am 24:109-27. 2010
  4. ncbi Extending the horizon for cell-based immunotherapy by understanding the mechanisms of action of photopheresis
    Ching Y Voss
    Center for Cancer and Blood Disorders, Children s National Medical Center, Washington, DC 20010, USA
    Transfus Med Rev 24:22-32. 2010
  5. ncbi Expanding options to improve outcomes following hematopoietic stem cell transplantation
    Terry J Fry
    Division of Blood and Marrow Transplantation, Children s National Medical Center, Washington, District of Columbia, USA
    Pediatr Blood Cancer 55:1043-4. 2010
  6. ncbi IL-7 in allogeneic transplant: clinical promise and potential pitfalls
    Kristen M Snyder
    Immunology Section, Pediatric Oncology Branch, Center for Cancer Research, NCI, NIH, Bethseda, MD 20892, USA
    Leuk Lymphoma 47:1222-8. 2006
  7. ncbi Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets
    Claude Sportes
    Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA
    J Exp Med 205:1701-14. 2008
  8. ncbi Cytokine signals in T-cell homeostasis
    Martin Guimond
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892-1104, USA
    J Immunother (1997) 28:289-94. 2005
  9. ncbi Escape from immune surveillance does not result in tolerance to tumor-associated antigens
    Fraia Melchionda
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA
    J Immunother (1997) 27:329-38. 2004
  10. ncbi Interleukin 7 worsens graft-versus-host disease
    Manoj L Sinha
    Pediatric Oncology Branch, Experimental Transplantation and Immunology Branch, National Cancer Institute, and Veterinary Resources Program, National Institutes of Health, Bethesda, MD 20892, USA
    Blood 100:2642-9. 2002

Collaborators

Detail Information

Publications11

  1. ncbi Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?
    Terry J Fry
    Division, Blood Marrow Transplantation and Immunology, Center for Cancer and Blood Disorders, Children s National Medical Center, Washington, DC 10010, USA
    Pediatr Clin North Am 55:147-67, xi. 2008
    ..In this article, we briefly provide a general overview of our current understanding of the immune system, with a focus on concepts in tumor immunology, followed by a discussion of how these concepts are being used in the clinic...
  2. ncbi The graft-versus-tumor effect in pediatric malignancy
    Terry J Fry
    Division of Blood and Marrow Transplantation Immunology, Center for Cancer and Blood Disorders, Children s National Medical Center, 1 West Wing, 111 Michigan Avenue, NW, Washington, DC 20010, USA
    Pediatr Clin North Am 57:67-81. 2010
    ....
  3. ncbi Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?
    Terry J Fry
    Division, Blood Marrow Transplantation and Immunology, Center for Cancer and Blood Disorders, Children s National Medical Center, 111 Michigan Avenue NW, Washington, DC 10010, USA
    Hematol Oncol Clin North Am 24:109-27. 2010
    ..In this article, we briefly provide a general overview of our current understanding of the immune system, with a focus on concepts in tumor immunology, followed by a discussion of how these concepts are being used in the clinic...
  4. ncbi Extending the horizon for cell-based immunotherapy by understanding the mechanisms of action of photopheresis
    Ching Y Voss
    Center for Cancer and Blood Disorders, Children s National Medical Center, Washington, DC 20010, USA
    Transfus Med Rev 24:22-32. 2010
    ..Such immunotherapy interventions could bring significant clinical benefit to patients undergoing transplant rejection or autoimmune-related disorders and deserve further investigation as well as validation studies...
  5. ncbi Expanding options to improve outcomes following hematopoietic stem cell transplantation
    Terry J Fry
    Division of Blood and Marrow Transplantation, Children s National Medical Center, Washington, District of Columbia, USA
    Pediatr Blood Cancer 55:1043-4. 2010
    ..However, the risk of treatment-related mortality remains approximately 5-10%, in part due to complications such as veno-occlusive disease (VOD) for which there has been less progress...
  6. ncbi IL-7 in allogeneic transplant: clinical promise and potential pitfalls
    Kristen M Snyder
    Immunology Section, Pediatric Oncology Branch, Center for Cancer Research, NCI, NIH, Bethseda, MD 20892, USA
    Leuk Lymphoma 47:1222-8. 2006
    ..Thus, careful consideration of how best to incorporate IL-7 into allogeneic trials will be needed if the full potential of this agent is to be realized...
  7. ncbi Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets
    Claude Sportes
    Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA
    J Exp Med 205:1701-14. 2008
    ....
  8. ncbi Cytokine signals in T-cell homeostasis
    Martin Guimond
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892-1104, USA
    J Immunother (1997) 28:289-94. 2005
    ....
  9. ncbi Escape from immune surveillance does not result in tolerance to tumor-associated antigens
    Fraia Melchionda
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA
    J Immunother (1997) 27:329-38. 2004
    ....
  10. ncbi Interleukin 7 worsens graft-versus-host disease
    Manoj L Sinha
    Pediatric Oncology Branch, Experimental Transplantation and Immunology Branch, National Cancer Institute, and Veterinary Resources Program, National Institutes of Health, Bethesda, MD 20892, USA
    Blood 100:2642-9. 2002
    ..These results suggest that use of IL-7 should be limited to the setting of TCD BMT to obtain the greatest benefit on immune competence with the least toxicity...
  11. ncbi Current concepts of thymic aging
    Terry J Fry
    Pediatric Oncology Branch, National Cancer Institute, Bldg. 10, Rm. 13N240, 10 Center Dr. MSC 1928, Bethesda, MD 20892-1928, USA
    Springer Semin Immunopathol 24:7-22. 2002